Uncategorised - Page 33

Tourette Syndrome Pipeline 2026: Investigational Therapies, Clinical Trial Advances, and Key Regulatory Developments by DelveInsight

According to DelveInsight’s latest evaluation, the global Tourette syndrome treatment pipeline features more than 6 prominent companies actively advancing over 6 investigational therapies. The comprehensive assessment covers ongoing clinical trials, therapeutic candidates, mechanisms of action, administration routes, and notable developmental milestones. The
25 March 2026

Structural Heart Devices Market Poised for Significant Growth, Projected to Reach ~USD 25 Billion by 2032 Driven by Increasing Adoption of Minimally Invasive Therapies | DelveInsight

DelveInsight’s Structural Heart Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Structural Heart Devices Companies market shares, challenges, Structural Heart Devices Market Drivers, barriers, trends, and key market Structural Heart Devices companies in the market. To
22 January 2026

Global Embolic Protection Devices Market Poised for Robust Expansion, Projected to Grow at a CAGR of ~8% Through 2032 | DelveInsight

DelveInsight’s Embolic Protection Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Embolic Protection Devices Companies market shares, challenges, Embolic Protection Devices Market Drivers, barriers, trends, and key market Embolic Protection Devices companies in the market. To
22 January 2026

Erectile Dysfunction Devices Market Poised for Robust Growth, Expected to Expand at ~8% CAGR Through 2032 Driven by Increasing Global Demand and Technological Innovation | DelveInsight

DelveInsight’s Erectile Dysfunction Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Erectile Dysfunction Devices Companies market shares, challenges, Erectile Dysfunction Devices Market Drivers, barriers, trends, and key market Erectile Dysfunction Devices companies in the market. To
22 January 2026
Chemotherapy-Induced Peripheral Neuropathy Market

CIPN Market Size was around USD 1,500 million in 2023

The chemotherapy-induced peripheral neuropathy (CIPN) treatment market is emerging as a high-growth, high-value opportunity, fueled by a profound lack of approved therapies and a substantial unmet clinical need. As the global use of chemotherapy particularly neurotoxic agents continues to rise, the number
21 January 2026

Choroidal Neovascularization Market Expected to Experience Rapid Growth During 2025–2034 Driven by Advancements in Anti-VEGF Therapies | DelveInsight

The choroidal neovascularization therapeutics market is anticipated to grow further, driven by key factors such as the increasing prevalence of the condition, technological advancements, and emerging therapies—including AbbVie and REGENXBIO’s ABBV-RGX-314, Adverum Biotechnologies’ Ixoberogene soroparvovec, Neuracle Genetics’ NG101, and others—over the forecast
20 November 2025

Global Pharmaceutical Contract Manufacturing Market Expected to Exceed USD 360 Billion by 2032 | DelveInsight

The pharmaceutical contract manufacturing market is witnessing robust growth, largely fueled by the increasing prevalence of chronic and infectious diseases. This expansion is further supported by the growing demand for biologics and biopharmaceuticals. Additionally, pharmaceutical and biotechnology companies are actively strengthening their
20 November 2025